News Sentiment

003060 sentiment intelligence

Aprogen Biologics Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 2 relevant articles
Exchange KSC South Korea
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 2085.00 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Guidance

58/100 classification confidence.

Company focus 2

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-1.0% over one week, -19.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Aprogen Biologics Inc. announced that it expects to receive KRW 2.000000772 billion in funding from Aprogen, Inc.

Market Reaction

Balanced read

50/100 confidence

News tone and price action are not far from neutral.

Primary event Guidance 58/100 classification
One-week reaction -1.0% Price digesting
Trend fit Trend inactive -19.0% over four weeks
Fair value -87.3% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 2
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 2
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
marketscreener.com 1
TradingView 1

Event Lens

What the news is about

Classified themes
Guidance 1
Earnings 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-2 of 2